C. Hadad et al. / Tetrahedron Letters 50 (2009) 1902–1905
1905
added followed, after 10 h stirring, by the GC1 dendrimer (49 mg, 0.027 mmol).
The resulting mixture was stirred at room temperature during 14 h. Cesium
salts were eliminated by centrifugation and the floating solution was
evaporated under reduced pressure to give a yellow solid. This one was
(192H), 6.67–7.23 (276H), 7.46–7.80 (126H) ppm. 13C NMR (62.9 MHz, CDCl3):
d 21.6–21.7, 33.0, 61.9, 68.4, 70.2, 70.7, 98.2, 117.8, 121.8, 122.5, 128.3, 132.3,
140.0, 146.1, 151.2, 154.3, 169.3–169.9 ppm. 31P NMR (101.5 MHz, CDCl3): d
8.26, 62.16, 64.55 ppm. Calcd for C1152H1248N87O474P45S42: C, 51.94; H, 4.72; N,
4.57; S, 5.06. Found for C, 51.32; H, 4.61; N, 4.77; S, 4.45.
washed by
a mixture Et2O/pentane (1:1) and isolated by centrifugation.
Phosphorous glycodendrimer GX1 was therefore obtained as a yellow powder
(150.5 mg, 96%). Mp 133 °C. IR (KBr): 3417 (F), 1755 (F), 1643 (f), 1501 (m),
15. Typical procedure for preparation of phosphorous glycodendrimer GX01: To a
solution of phosphorous glycodendrimer GX1 (238 mg, 0.041 mmol) in
a
1222 (F), 1183 (m) cmꢀ1 1H NMR (250 MHz, CDCl3): d 2.03 (s, 108H), 3.22 (d,
.
MeOH/CH2Cl2 mixture (1:1) (20 ml) was added dropwise a 0.5 M NaOMe
J = 10.13 Hz, 18H), 3.50 (dd, J = 7.9, 11.9 Hz, 12H), 4.28 (dd, J = 4.7, 11.9 Hz,
12H), 4.90–5.28 (48H), 6.80–7.15 (60H), 7.51–7.69 (18H) ppm. 13C NMR
(62.9 MHz, CDCl3): d 20.6–20.7, 33.0 (d, J = 12.17 Hz), 61.9, 68.4, 70.1, 70.7,
98.9, 117.8, 121.3, 122.4, 128.3, 132.2, 138.7 (d, J = 6.9 Hz), 145.8, 151.2, 153.9,
169.3–169.9 ppm. 31P NMR (101.5 MHz, CDCl3): d 8.52, 63.49 ppm. Calcd for
C252H276N15O114P9S6: C, 52.09; H, 4.79; N, 3.62; S, 3.31. Found for C, 52.02; H,
4.84; N, 3.72; S, 3.19.
solution (1.5 mL, 0.738 mmol, 18 equiv). After 2 hours stirring at room
temperature, phosphorous glycodendrimer GX10 was precipitated and
isolated by centrifugation as a beige powder (170 mg, 96%). Mp 172 °C. IR
(KBr): 3409 (F), 1600 (F), 1501 (m), 1185 (F), 1102 (m) cmꢀ1 1H NMR
.
(250 MHz, D2O): d 3.27–3.68 (54H), 3.72–4.23 (24H), 4.90–5.15 (12H), 7.10–
7.35 (60H), 7.51–7.69 (18H) ppm. 13C NMR (62.9 MHz, D2O):
d
33.8 (d,
J = 11.9 Hz), 66.7, 70.5, 74.2, 77.3, 102.8, 118.7, 122.1, 122.9, 129.3, 133.7, 140.3
(d, J = 15.4 Hz), 146.3 (d, J = 6.6 Hz), 152.2, 156.0 ppm. 31P NMR (101.5 MHz,
D2O): d 9.10, 64.33 ppm. Phosphorous glycodendrimer GX02: Similar procedure
14. Phosphorous glycodendrimer GX2: Similar procedure as for phosphorous
glycodendrimer
xylopyranoside
GX1
with
parahydroxyphenyl-2,3,4-tri-O-acetyl-b-D-
1
(243 mg, 0.660 mmol, 48 equiv), cesium carbonate
as for phosphorous glycodendrimer GX01 with
a
0.5 M NaOMe solution
(1.05 mL, 0.508 mmol, 36 equiv) and the GX2 dendrimer (180 mg,
0.014 mmol). Phosphorous glycodendrimer GX02 was obtained as
beige
powder (136 mg, 100%). Mp 196 °C. IR (KBr): 3408 (F), 1601 (F), 1501 (m), 1186
(m), 1101 (f) cmꢀ1 1H NMR (250 MHz, D2O): d 3.25–3.50 (78H), 3.55–3.65
(430 mg, 1.320 mmol, 96 equiv) and the GC2 dendrimer (65 mg,
0.014 mmol). Phosphorous glycodendrimer GX2 was obtained as a yellow
powder (160 mg, 90%). Mp 145 °C. IR (KBr): 3418 (F), 1757 (f), 1642 (m), 1501
a
(f), 1265 (m), 1224 (m) cmꢀ1
.
1H NMR (250 MHz, CDCl3): d 2.05 (s, 216H), 3.10–
.
3.38 (54H), 3.50 (dd, J = 7.9, 11.9 Hz, 24H), 4.28 (dd, J = 4.7, 11.9 Hz, 24H), 4.90–
5.28 (96H), 6.80–7.15 (132H), 7.51–7.69 (54H) ppm. 13C NMR (62.9 MHz,
CDCl3): d 21.2, 33.5, 62.3, 68.9, 70.6, 71.2, 99.2, 118.3, 121.8, 122.2, 122.9,
128.6, 132.5, 132.8, 139.1–139.4, 146.1, 151.7, 153.3, 169.3–169.9 ppm. 31P
NMR (101.5 MHz, CDCl3): d = 8.76, 62.99, 64.55 ppm. Calcd for
C552H600N39O234P21S18: C, 51.99; H, 4.74; N, 4.28; S, 4.53. Found for C, 51.24;
H, 4.80; N, 4.32; S, 4.25. Phosphorous glycodendrimer GX3: Similar procedure as
for phosphorous glycodendrimer GX1 with parahydroxyphenyl-2,3,4-tri-O-
(48H), 3.70–3.90 (24H), 3.95–4.05 (24H), 4.90–5.00 (24H), 7.10–7.45 (132H),
7.80–8.02 (54H) ppm. 13C NMR (62.9 MHz, D2O): d 33.7–33.9, 66.7, 70.6, 74.3,
77.3, 103.0, 118.8, 122.7, 123.1, 123.2, 129.4, 133.7, 134.0, 140.1–140.4, 146.5
(d, J = 6.9 Hz), 152.5, 156.1 ppm. 31P NMR (101.5 MHz, D2O): d 9.35, 62.65,
64.64 ppm. Phosphorous glycodendrimer GX03: Similar procedure as for
phosphorous glycodendrimer GX01 with a 0.5 M NaOMe solution (0.9 mL,
0.450 mmol, 72 equiv) and the GX3 dendrimer (166 mg, 0.006 mmol).
Phosphorous glycodendrimer GX03 was obtained as a beige powder (125 mg,
100%). Mp 199 °C. IR (KBr): 3408 (F), 1604 (F), 1501 (m), 1187 (f), 1100 (f)
acetyl-b-
D-xylopyranoside
1
(197 mg, 0.535 mmol, 96 equiv), cesium
carbonate (343 mg, 1.054 mmol, 192 equiv) and the GC3 dendrimer (69 mg,
0.006 mmol). Phosphorous glycodendrimer GX3 was obtained as a yellow
powder (135 mg, 90%). Mp 150 °C. IR (KBr): 3415 (F), 1757 (F), 1642 (f), 1501
cmꢀ1 1H NMR (250 MHz, D2O): d 3.25–3.40 (174H), 3.45–4.40 (192H), 4.95–
.
5.05 (48H), 7.10–7.45 (276H), 7.81–8.12 (126H) ppm. 13C NMR (62.9 MHz,
D2O): d 33.5–33.7, 66.4, 70.3, 74.0, 77.0, 102.7, 118.5, 122.2, 122.8–123.0,
129.1–129.2, 133.6–133.7, 140.1–140.6, 146.3, 152.4–152.6, 155.8 ppm. 31P
NMR (101.5 MHz, D2O): d 8.82, 62.92, 64.43 ppm.
(m), 1266 (F), 1225 (m) cmꢀ1 1H NMR (250 MHz, CDCl3): d 1.85–2.04 (432H),
.
3.07–3.40 (126H), 3.04-3.58 (48H), 4.16 (dd, J = 3.5, 11.4 Hz, 48H), 4.86–5.28